These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 27292647)
1. Migration Phenotype of Brain-Cancer Cells Predicts Patient Outcomes. Smith CL; Kilic O; Schiapparelli P; Guerrero-Cazares H; Kim DH; Sedora-Roman NI; Gupta S; O'Donnell T; Chaichana KL; Rodriguez FJ; Abbadi S; Park J; Quiñones-Hinojosa A; Levchenko A Cell Rep; 2016 Jun; 15(12):2616-24. PubMed ID: 27292647 [TBL] [Abstract][Full Text] [Related]
2. The mode and dynamics of glioblastoma cell invasion into a decellularized tissue-derived extracellular matrix-based three-dimensional tumor model. Koh I; Cha J; Park J; Choi J; Kang SG; Kim P Sci Rep; 2018 Mar; 8(1):4608. PubMed ID: 29545552 [TBL] [Abstract][Full Text] [Related]
5. Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro. Engebraaten O; Bjerkvig R; Pedersen PH; Laerum OD Int J Cancer; 1993 Jan; 53(2):209-14. PubMed ID: 8381111 [TBL] [Abstract][Full Text] [Related]
6. Differential response of patient-derived primary glioblastoma cells to environmental stiffness. Grundy TJ; De Leon E; Griffin KR; Stringer BW; Day BW; Fabry B; Cooper-White J; O'Neill GM Sci Rep; 2016 Mar; 6():23353. PubMed ID: 26996336 [TBL] [Abstract][Full Text] [Related]
7. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness. Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038 [TBL] [Abstract][Full Text] [Related]
8. Extracellular adenosine promotes cell migration/invasion of Glioblastoma Stem-like Cells through A Torres Á; Erices JI; Sanchez F; Ehrenfeld P; Turchi L; Virolle T; Uribe D; Niechi I; Spichiger C; Rocha JD; Ramirez M; Salazar-Onfray F; San Martín R; Quezada C Cancer Lett; 2019 Apr; 446():112-122. PubMed ID: 30660649 [TBL] [Abstract][Full Text] [Related]
9. Cadherin-dependent adhesion of human U373MG glioblastoma cells promotes neurite outgrowth and increases migratory capacity. Laboratory investigation. Cifarelli CP; Titus B; Yeoh HK J Neurosurg; 2011 Mar; 114(3):663-9. PubMed ID: 20415527 [TBL] [Abstract][Full Text] [Related]
10. Tapered microtract array platform for antimigratory drug screening of human glioblastoma multiforme. Cha J; Koh I; Choi Y; Lee J; Choi C; Kim P Adv Healthc Mater; 2015 Feb; 4(3):405-11. PubMed ID: 25230171 [TBL] [Abstract][Full Text] [Related]
11. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Natarajan M; Stewart JE; Golemis EA; Pugacheva EN; Alexandropoulos K; Cox BD; Wang W; Grammer JR; Gladson CL Oncogene; 2006 Mar; 25(12):1721-32. PubMed ID: 16288224 [TBL] [Abstract][Full Text] [Related]
12. The impact of phenotypic switching on glioblastoma growth and invasion. Gerlee P; Nelander S PLoS Comput Biol; 2012; 8(6):e1002556. PubMed ID: 22719241 [TBL] [Abstract][Full Text] [Related]
13. Cdh4 Down-Regulation Impairs in Vivo Infiltration and Malignancy in Patients Derived Glioblastoma Cells. Ceresa D; Alessandrini F; Bosio L; Marubbi D; Reverberi D; Malatesta P; Appolloni I Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426573 [TBL] [Abstract][Full Text] [Related]
14. An advanced glioma cell invasion assay based on organotypic brain slice cultures. Eisemann T; Costa B; Strelau J; Mittelbronn M; Angel P; Peterziel H BMC Cancer; 2018 Jan; 18(1):103. PubMed ID: 29378533 [TBL] [Abstract][Full Text] [Related]
15. Cancer stem-like cells of glioblastoma characteristically express MMP-13 and display highly invasive activity. Inoue A; Takahashi H; Harada H; Kohno S; Ohue S; Kobayashi K; Yano H; Tanaka J; Ohnishi T Int J Oncol; 2010 Nov; 37(5):1121-31. PubMed ID: 20878060 [TBL] [Abstract][Full Text] [Related]
16. Protein kinase A-dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived-growth factor receptor α. Feng H; Li Y; Yin Y; Zhang W; Hou Y; Zhang L; Li Z; Xie B; Gao WQ; Sarkaria JN; Raizer JJ; James CD; Parsa AT; Hu B; Cheng SY Neuro Oncol; 2015 Jun; 17(6):832-42. PubMed ID: 25468898 [TBL] [Abstract][Full Text] [Related]
17. Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities. Memmel S; Sisario D; Zöller C; Fiedler V; Katzer A; Heiden R; Becker N; Eing L; Ferreira FLR; Zimmermann H; Sauer M; Flentje M; Sukhorukov VL; Djuzenova CS Oncotarget; 2017 Jul; 8(28):45298-45310. PubMed ID: 28424411 [TBL] [Abstract][Full Text] [Related]
18. Glioblastoma quo vadis: Will migration and invasiveness reemerge as therapeutic targets? Lefranc F; Le Rhun E; Kiss R; Weller M Cancer Treat Rev; 2018 Jul; 68():145-154. PubMed ID: 30032756 [TBL] [Abstract][Full Text] [Related]
19. Time-lapse phenotyping of invasive glioma cells ex vivo reveals subtype-specific movement patterns guided by tumor core signaling. Fayzullin A; Tuvnes FA; Skjellegrind HK; Behnan J; Mughal AA; Langmoen IA; Vik-Mo EO Exp Cell Res; 2016 Dec; 349(2):199-213. PubMed ID: 27515001 [TBL] [Abstract][Full Text] [Related]